Innovation, Translation, Impact
The Institute of Biomedical Engineering (IBME) provides a much-needed focus for UCL’s wide-ranging expertise in medical technologies: more than 150 principal investigators and their teams – a thousand or more researchers – are working in 35 institutes, departments and centres across the entire breadth of the university.
The UCL Institute of Biomedical Engineering (IBME) has high ambitions – no less than to be one of the world’s best university-based proponents of medical technologies R&D, and of its successful translation into products of significant patient benefit and real commercial value.
Our goals are then:
To bring together UCL’s excellence in academic and clinical R&D – around a thousand staff, fellows, nurses and students in 35 different centres, departments and institutes – to create the world’s best research centre for biomedical engineering.
To be the world’s fastest and most cost-effective deliverer of patient benefit by harnessing the power of university-based innovation and experimental medicine in the UK.